Beeline Medicines
The Director, CMC Analytical Development – Biologics leads the development and validation of analytical methods for biologics drug substance and drug product programs. This role ensures analytical readiness across development milestones and partners with cross-functional teams to embed robust analytical science into the biologics development pipeline.
Beeline Medicines is a clinical-stage biotechnology company focused on developing and delivering category-leading precision therapies that target the drivers of immune dysfunction. The company is advancing a pipeline of therapies for autoimmune and inflammatory diseases, including its lead program afimetoran, a TLR7/8 inhibitor in late-stage clinical development for lupus. Beeline Medicines aims to define new treatment paradigms for patients living with chronic immune-mediated conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Beeline Medicines.
8% above the average for this role
Advisor - Analytical Development CMC
Eli Lilly and Company
Associate Principal Scientist, Analytical R&D
MSD
Senior Scientist, Analytical Development and Quality Control (Drug Product)
Nurix
Director, Analytical Chemistry Extended Characterization
Eli Lilly and Company
Scientist, Analytical Sciences & Technology
jobdiva
(CW) Sr Research Associate II
biomarin